Join us for “Women in Psychedelic Leadership: Driving Innovation and Governance” a powerful panel featuring visionary women at the forefront of psychedelic leadership. This conversation highlights voices across nonprofit, academic, corporate, and spiritual sectors who are driving scientific innovation, ethical leadership, corporate strategy, cultural integrity, academic inquiry, and advocacy in the evolving psychedelic landscape.

From historical foundations to cutting-edge developments, our panelists will explore how women are influencing the trajectory of psychedelic research, governance, healing, and public discourse. Whether you’re engaged in the space or newly curious, this webinar offers essential insights into the values and vision shaping the future of psychedelics.

Join us for a groundbreaking conversation exploring how psychedelic therapy is transforming end-of-life care and offering new pathways to healing, acceptance, and profound peace in life's final chapter.

This intimate webinar brings together four extraordinary voices: a pioneering physician integrating psychedelic medicine into palliative care, a professor of Nursing and Chair of Psychedelic Assisted Therapy unveiling the latest clinical findings, a compassionate death doula guiding families through transition, and a courageous individual with stage 4 cancer sharing their personal journey with psychedelic-assisted therapy.

Whether you're a healthcare professional, someone facing a terminal diagnosis, a family member seeking alternatives, or simply curious about this revolutionary intersection of consciousness and medicine, this webinar offers hope, scientific insight, and deeply human stories of transformation.

This isn't just about dying differently—it's about living more fully.

Join the Psychedelic Association of Canada for a groundbreaking conversation on the use of ibogaine as a treatment for traumatic brain injury (TBI) in professional athletes.

Concussion and TBI are a silent epidemic in pro sports. Athletes suffer in silence for years during and after their pro careers end, often misdiagnosed or left with treatments that manage symptoms but fail to heal the root injury. Now, emerging research and real-world outcomes suggest that ibogaine may offer a breakthrough path to recovery, restoring function, reducing brain age, and giving athletes their lives back.

Hosted by Ambio Life Sciences Co-Founder Trevor Millar, with special guest Ales Hemsky – former NHL star and ibogaine patient – this panel explores the science of ibogaine for TBI, lived experience, and emerging promise of ibogaine therapy for athletes facing the long-term impacts of repetitive head injury, mental health issues, and the downstream effects of untreated conditions.

With recent clinical research from Ambio and Stanford University showing ibogaine’s potential to reverse brain aging and restore function in TBI patients, this discussion sheds light on one of the most pressing and under-addressed issues in sports and brain health, revealing ibogaine as a powerful new tool to help.

‍